Yaroslavl Pharma Cluster: Evident Prospects
Significant issues of the pharmaceutical industry were discussed at the working session of the Association of Modern Pharmaceutical Industry and Innovative Medicine of Yaroslavl Region (Yaroslavl Pharmaceutical Cluster) held on April, 5 at the Government of Yaroslavl region.
Administrative development of the cluster, international cooperation, target support of the cluster from the federal budget were the key issues discussed at the meeting. It was acknowledged, that pharma cluster participants significantly contribute to implementation of the priority program of import substitution, ensure increased availability of drugs for citizens. It was not by accident that pharmaceutics is at the focus of the government of the Moscow region. R-Pharm, Takeda, Teva have already established manufacture in the territory of the pharma cluster. A common use center at the Chemo-Technological Lyceum began its work, construction works on technology transfer center and drug certification center are ongoing.
In particular, a large investment project for construction of a vaccine and drug production facility of NTPharma LLC in Pereslavl region was discussed at the meeting.
Prospects of further development of pharma industry in the region are evident. From the time of launch of the project 3.7 bln rubles went to regional budget as taxes, about 540 work places have been created.